Results
20
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
20 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
RVIC | US$0.27 | 2.3% | -91.0% | US$5.7m | n/a | PB0.08x | n/a | 428.0% | ||
CTRE | US$30.66 | 1.0% | 33.6% | US$5.8b | US$33.67 | PB2.4x | E45.5% | 3.8% | ||
EQC | US$20.12 | 0.8% | 5.4% | US$2.2b | US$20.50 | PB0.9x | n/a | 0% | ||
IIPR | US$105.30 | 2.2% | 31.6% | US$3.0b | US$135.40 | PB1.6x | E2.3% | 7.2% | ||
NLCP | US$18.92 | 9.8% | 45.5% | US$411.5m | US$23.50 | PB1x | E-2.3% | 9.1% | ||
CURB | US$23.87 | -1.2% | n/a | US$2.5b | US$24.95 | PB2.2x | E30.1% | n/a | ||
SILA | US$25.45 | 4.6% | n/a | US$1.4b | US$28.33 | PB1x | E8.4% | 6.3% | ||
SITC | US$16.12 | 1.4% | -69.4% | US$847.3m | US$24.08 | PB0.3x | E-118.9% | 0% | ||
TRNO | US$59.93 | -3.0% | 7.4% | US$6.0b | US$70.33 | PB1.6x | E9.9% | 3.3% | ||
SELF | US$5.31 | 2.8% | 14.9% | US$58.0m | US$6.50 | PB1.2x | E-25.4% | 5.5% | ||
BHM | US$14.35 | -0.3% | -1.4% | US$186.9m | n/a | PB0.4x | n/a | 7.0% | ||
NLOP | US$31.12 | -1.0% | 98.1% | US$458.0m | US$46.00 | PB0.7x | n/a | 1.1% | ||
LVVR | US$3.40 | 0% | n/a | US$43.5m | n/a | PB0.8x | n/a | 4.4% | ||
WY | US$30.67 | -0.7% | -4.1% | US$22.3b | US$36.80 | PB2.2x | E21.4% | 3.1% | ||
AHR New | US$27.66 | 3.2% | n/a | US$4.4b | US$29.00 | PB1.9x | E55.6% | 3.6% | ||
CHTH | US$4.00 | 0% | -9.3% | US$695.8m | n/a | PB1x | n/a | 2.6% | ||
PW | US$1.03 | -2.8% | 55.0% | US$3.7m | n/a | PB2.7x | n/a | 0% | ||
SQFT New | US$0.50 | -26.8% | -47.9% | US$6.6m | n/a | PB0.2x | n/a | 0% | ||
GIPR New | US$1.85 | 1.1% | -52.4% | US$9.4m | n/a | PB1.6x | E15.3% | 0% | ||
SLVS | US$0.35 | -7.9% | n/a | US$23.2m | n/a | PB0.1x | n/a | n/a |